El-Agnaf; Omar M. Ali
Patent Applications and Registrations
Patent applications and USPTO patent grants for El-Agnaf; Omar M. Ali.The latest application filed is for "alpha-synuclein antibodies (7a11)".
- El-Agnaf; Omar M. Ali - Morecambe UA
| Patent | Date |
|---|---|
| RVG Derived peptides Grant 10,548,984 - El-Agnaf Fe | 2020-02-04 |
| Compounds for use as imaging agents Grant 10,488,417 - El-Agnaf Nov | 2019-11-26 |
| Alpha-Synuclein Antibodies (4H6) App 20180134776 - El-Agnaf; Omar M. Ali ; et al. | 2018-05-17 |
| Alpha-Synuclein Antibodies (11D12) App 20180134777 - El-Agnaf; Omar M. Ali ; et al. | 2018-05-17 |
| Alpha-Synuclein Antibodies (7A11) App 20180134775 - El-Agnaf; Omar M. Ali ; et al. | 2018-05-17 |
| Rvg Derived Peptides App 20180028675 - El-Agnaf; Omar M. Ali | 2018-02-01 |
| Compounds For Use As Imaging Agents App 20170307623 - El-Agnaf; Omar M. Ali | 2017-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 